Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for ...
'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic ...
Pharmaceutical Technology on MSN
Cellular Intelligence licenses Novo’s shelved Parkinson’s cell therapy programme
Novo Nordisk shuttered its cell therapy unit in October 2025, with assets now moving to new hands.
Ozempic maker Novo Nordisk agreed to sell an experimental cell therapy for Parkinson's disease to Cellular Intelligence and take a stake in the U.S. startup, Cellular Intelligence said Monday.
Novo Nordisk has sold the rights to one of the flagship candidates in its now-defunct cell therapy unit, which was wound down ...
The startup, Cellular Intelligence, is gaining rights to the early-stage treatment and will be in charge of shepherding it ...
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk. Anthropic (and ...
PD, a shelved Parkinson's cell therapy, to AI biotech Cellular Intelligence in return for equity and milestones.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results